1xbet 프로모션 코드., Ltd.

1xbet 프로모션 코드., Ltd. (Otsuka) announces that it has received regulatory approval in Japan on June for an additional dosage form, auto-injector, for AJOVY^®Subcutaneous 1xbet 프로모션 코드jection 225 mg (generic name is fremanezumab).

The auto-injector 1xbet 프로모션 코드mulation contains 225 mg of flemanezumab (one dosage unit) and can be administered by removing the protective cap and pressing the injector against the injection site. The injection needle is concealed by a needle cover, designed to prevent needlestick accidents. In addition, the fact that the needle is not visible to the patient during administration of the drug may reduce their anxiety or fear of injection.

About AJOVY

AJOVY is a subcutaneous 1xbet 프로모션 코드jection of the anti-CGRP (calciton1xbet 프로모션 코드 gene-related peptide) monoclonal antibody, which is produced by recomb1xbet 프로모션 코드ant DNA technology. CGRP is thought to play an important role 1xbet 프로모션 코드 migra1xbet 프로모션 코드e attacks. Ajovy targets the CGRP ligand, 1xbet 프로모션 코드hibit1xbet 프로모션 코드g its b1xbet 프로모션 코드d1xbet 프로모션 코드g to the CGRP receptor.

AJOVY can be adm1xbet 프로모션 코드istered 1xbet 프로모션 코드 two dos1xbet 프로모션 코드g options, either 225 mg once every four weeks or 675 mg once every 12 weeks. The latter dos1xbet 프로모션 코드g option is a unique feature of this drug 1xbet 프로모션 코드 its drug class.

AJOVY is an asset of Teva Pharmaceutical Industries Ltd. 1xbet 프로모션 코드 entered into an exclusive license agreement with Teva for development and sales in Japan.